-
Mashup Score: 15
Our understanding of schizophrenia has increased greatly in recent years, as studies of large groups of people have identified a multitude of genetic variants that increase a person’s risk of the disease. …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7The Gut Microbiome Looks Different for People With Treatment-Resistant Schizophrenia - 1 month(s) ago
Investigators suggested that this difference is caused by a common medication for treatment-resistant schizophrenia.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysis - 2 month(s) ago
The GRADE framework indicated that the quality of the evidence among the included studies was moderate, primarily due to the limited number of randomised controlled trials with a low risk of bias. Important drugs did not appear in these results due to insufficient low-risk-of-bias data for these medications. These results highlight new pathways for treating schizophrenia that should be incorporated into future guidelines after further validation.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
No causal relationship can be inferred from the current results. The findings could be in favor of both a detrimental and beneficial effect of cannabis on positive and negative symptoms, respectively. Longitudinal designs are needed to understand the role of cannabis is this association. The reported effect sizes are small and CIs are wide, the interpretation of findings should be taken with caution.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials - 2 month(s) ago
Findings suggest that the effectiveness of CBT on general and positive symptoms in SSD at EoT was small to medium, while we found inconsistent evidence for a sustainable effect. CBT has no convincing impact on other relevant outcomes. Guidelines may use these results to specify their recommendations.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Spike in Schizophrenia-Related ED Visits During COVID - 3 month(s) ago
Emergency room visits for schizophrenia spectrum disorders increased by 15% following the initial phase of the COVID-19 pandemic, data from a large observational study showed.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6Sleep Quality in Patients With Schizophrenia - 3 month(s) ago
Most patients with schizophrenia suffered significantly from poor sleep quality, deleteriously impacting their daytime functioning,
Source: www.psychiatrist.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0
In a phase 3 EMERGENT-2 trial, the study found 55% of participants with schizophrenia taking xanomeline-trospium had a ≥30% improvement from baseline to week 5, compared to the placebo group.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Sleep Quality in Patients With Schizophrenia - 3 month(s) ago
Most patients with schizophrenia suffered significantly from poor sleep quality, deleteriously impacting their daytime functioning,
Source: www.psychiatrist.comCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0
In a phase 3 EMERGENT-2 trial, the study found 55% of participants with schizophrenia taking xanomeline-trospium had a ≥30% improvement from baseline to week 5, compared to the placebo group.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
Discovery hints at genetic basis for the most challenging symptoms of #schizophrenia https://t.co/cndNLwTR4p